Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05751473 · ClinicalTrials.gov registry record · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
A NA study of Post Traumatic Stress Disorder, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 12
- Study locations
NCT05751473: Recruiting NA study of Post Traumatic Stress Disorder, sponsored by University of Michigan.
NCT05751473 is a NA study of Post Traumatic Stress Disorder that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 410 participants, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (38% lower). The trial reports 12 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05751473, a NA study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study addresses PTSD symptoms in First Responders and Healthcare workers. Specifically, it tests whether a brief PTSD treatment (talk therapy) effectively treats PTSD when provided to First Responders and Healthcare workers by counselors in Employee Assistance Programs (EAPs). The central hypothesis is that the PTSD treatment, Prolonged Exposure for Primary Care (PE-PC), will reduce PTSD symptoms and improve functioning, compared to EAP Treatment as Usual (TAU).
Primary Outcome
The PCL-5 is a 20-item self-report measure that assesses symptoms of PTSD. The self-report rating scale is 0-4 for each symptom. The minimum and maximum values are 0 and 80, with higher scores indicating worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Prolonged Exposure for Primary Care (PE-PC)
- BEHAVIORAL EAP Treatment as Usual (TAU)
Study Locations (12)
Michigan
- University of Michigan - Ann Arbor
- Henry Ford Health System - Detroit
- Detroit Fire Department - Detroit
- Health Management Systems of America - Detroit
- Michigan State University - East Lansing
- West Bloomfield Fire Department - West Bloomfield
Ohio
- University of Cincinati Health - Cincinnati
- ProMedica - Fremont
California
- Sharp Healthcare - San Diego
Georgia
- Tanner Health System - Carrollton
New York
- Cope NewYork-Presbyterian - New York
Texas
- Houston Fire Department - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2023-05-16 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05751473 shows while recruiting
NCT05751473 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Prolonged Exposure for Primary Care (PE-PC) is the first listed.
NCT05751473 lists 12 locations in 6 states (Michigan, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT05751473 about?
NCT05751473 is a clinical study titled "Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers". This study addresses PTSD symptoms in First Responders and Healthcare workers. Specifically, it tests whether a brief PTSD treatment (talk therapy) effectively treats PTSD when provided to First Responders and Healthcare workers by counselors in Employee Assistance Programs (EAPs). The central hypo...
What is the current status of trial NCT05751473?
This trial is currently recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2023-05-16. Estimated completion is 2026-08-31.
What conditions does trial NCT05751473 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT05751473?
The interventions under investigation include: Prolonged Exposure for Primary Care (PE-PC) (BEHAVIORAL), EAP Treatment as Usual (TAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05751473?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05751473 being conducted?
This trial has 12 study locations across California, Georgia, Michigan, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05751473's enrollment target sits among peer trials
410 17th of 262 higher than 245 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT06064877 · 410 participants · Phase 3
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI